Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life.
Saved in:
| Title: | Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life. |
|---|---|
| Authors: | Ardeshir A; California National Primate Research Center, University of California, Davis, Davis, CA, USA.; Tulane National Primate Research Center, Tulane University, Covington, LA, USA., O'Hagan D; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA., Mehta I; Center for Systems Immunology, Departments of Immunology and Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA., Shandilya S; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA., Hopkins LLJ; California National Primate Research Center, University of California, Davis, Davis, CA, USA., Adamson L; California National Primate Research Center, University of California, Davis, Davis, CA, USA., Kuroda MJ; California National Primate Research Center, University of California, Davis, Davis, CA, USA., Hahn PA; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA., da Costa LAB; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA., Fuchs SP; Department of Pathology, University of Miami, Miami, FL, USA., Martinez-Navio JM; Department of Pathology, University of Miami, Miami, FL, USA., Gardner MR; Department of Medicine, Division of Infectious Disease, Emory University, Atlanta, GA, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, USA., Van Rompay KKA; California National Primate Research Center, University of California, Davis, Davis, CA, USA., Magnani DM; Nonhuman Primate Reagent Resource, UMass Chan Medical School, Worcester, MA, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Gao G; Department of Genetic and Cellular Medicine, UMass Chan Medical School, Worcester, MA, USA., Farzan M; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA.; Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Desrosiers RC; Department of Pathology, University of Miami, Miami, FL, USA., Das J; Center for Systems Immunology, Departments of Immunology and Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA., Martins MA; Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA. mauricio.martins@ufl.edu. |
| Source: | Nature [Nature] 2025 Sep; Vol. 645 (8082), pp. 1020-1028. Date of Electronic Publication: 2025 Jul 30. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
